Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Iran Darou is a prominent Iranian pharmaceutical company established in 1981, specializing in the production of a wide range of human medicines. The company's portfolio includes various dosage forms such as tablets, capsules, syrups, and topical ointments, covering therapeutic areas like dermatology, gastroenterology, and cardiovascular health. As a subsidiary of the Alborz Investment Group, it operates large-scale manufacturing facilities compliant with GMP standards. Iran Darou is recognized for its extensive distribution network within the Iranian market and its efforts in exporting products to neighboring regions. The company is publicly traded on the Tehran Stock Exchange under the symbol DARAVAR.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Iran Darou.